Evoke Pharma Inc expected to post a loss of 4  cents a share - Earnings Preview

Evoke Pharma

07/05/2022 01:56

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on May 10. 
    * The Solana Beach California-based  company is expected to
report
 a 494.4% increase in revenue to $535 thousand from $90 thousand
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Evoke Pharma Inc is
for a
loss of 4 cents per share. For the same quarter last year, the
company reported a loss of 8 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $9.5​, above​ its last closing price of $0.43. ​​​

This summary was machine generated May 7 at 00:56 GMT.  All
figures in US dollars  unless otherwise stated